Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer

Affiliations

• ¹ Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK. Electronic address: [email protected].
• ² Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
• ³ EAU Guidelines Office, Arnhem, The Netherlands.
• ⁴ Department of Urology, University Utrecht, Utrecht, The Netherlands.
• ⁵ Division of Cancer & Genetics, School of Medicine Cardiff University, Velindre Cancer Centre, Cardiff, UK.
• ⁶ Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
• ⁷ Department of Urology, The Austin Hospital, Melbourne, Australia.
• ⁸ Department of Urology, San Raffaele Hospital, Milan, Italy.
• ⁹ Department of Urology, University of Zurich, Zurich, Switzerland.
• ¹⁰ Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ¹¹ Department of Urology, Institut Montsouris, Paris, France.
• ¹² Department of Urology, Leto Hospital, Athens, Greece.
• ¹³ Department of Urology, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK.
• ¹⁴ Academic Urology Unit, University of Sheffield, Sheffield, UK.
• ¹⁵ School of Nursing and Midwifery, Robert Gordon University, Aberdeen, UK.
• ¹⁶ Department of Urology, University of Padova, Padova, Italy.
• ¹⁷ HagaZiekenhuis, The Hague, The Netherlands.
• ¹⁸ Department of Urology, University Hospital K.U. Leuven, Leuven, Belgium.
• ¹⁹ Department of Urology, University of Bern, Inselspital, Bern, Switzerland.
• ²⁰ Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
• ²¹ Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands.
• ²² Patient Advocate, Hasselt, Belgium.
• ²³ Service of Nuclear Medicine, S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
• ²⁴ Department of Urology, Charité University Hospital, Berlin, Germany.
• ²⁵ Department of Oncology/Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Division of Cancer Sciences, University of Manchester and The Christie, Manchester, UK.
• ²⁶ Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.
• ²⁷ Leeds Cancer Centre, St. James's University Hospital, Leeds, UK.
• ²⁸ Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands.
• ²⁹ Radiology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
• ³⁰ Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
• ³¹ Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
• ³² Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
• ³³ Department of Urology, University Hospital, St. Etienne, France.